Pablo Lubroth

Pablo Lubroth is the VP of Special Projects at Enveda Biosciences and an Investor at Hummingbird Ventures, based in London. He holds degrees from University College London and the University of Cambridge, and previously worked in corporate development for a genome editing company. At Hummingbird Ventures, he built the firm's biotech practice, focusing on pre-seed through Series B investments ranging from $500,000 to $5 million. His investment portfolio includes leading a $15 million round for Waypoint Bio in 2024, a $55 million round for Enveda Biosciences in 2022, and a $6 million round for Kaleidoscope, alongside angel investments in Cradle Bio and Bioptimus. Additionally, he co-founded Decoding Bio, a platform providing insights into the intersection of artificial intelligence and therapeutics. Lubroth currently focuses on advancing early-stage ventures and operational initiatives across the computational biology and biomanufacturing sectors.